The Efficacy of Lacosamide in Children with Drug-resistant Focal Epilepsy

No Thumbnail Available

Date

2021

Journal Title

Journal ISSN

Volume Title

Publisher

Open Access Color

OpenAIRE Downloads

OpenAIRE Views

Research Projects

Organizational Units

Journal Issue

Events

Abstract

Introduction: This study aimed to assess the efficacy, tolerability and adverse effects of Lacosamide (LCM) in children with refractory focal epilepsy. Methods: Children aged younger than 16 years with drug-resistant focal epilepsy were enrolled. The medical records and seizure diaries that were evaluated every three months were reviewed. Response to LCM was defined as ≥50% reduction in seizure frequency. Results: Twenty-five children with drug-resistant focal epilepsy received LCM as add-on therapy. The mean duration of epi- lepsy was 5.2 years and the mean age at LCM initiation was 8 years. The rate of response to LCM treatment in the 3th, 6th and 9th months were 44%, 64%, 76%, respectively. At the end of 12 months, the response rate was 84% and 16% of the patients were seizure free. Four patients had adverse effects; three patients were discontinued LCM and one improved after decreas- ing the dose of the drug. Discussion and Conclusion: LCM is an effective add-on antiepileptic drug for children with refractory focal epilepsy. It dimin- ishes the frequency of seizures over time. It is well tolerated and a promising option in these patients.

Description

Keywords

Turkish CoHE Thesis Center URL

Fields of Science

Citation

WoS Q

Scopus Q

Source

Haydarpaşa Numune Medical Journal

Volume

61

Issue

1

Start Page

52

End Page

57